ES2109512T3 - Macrolactama (ciclamenol) antiinflamatoria. - Google Patents
Macrolactama (ciclamenol) antiinflamatoria.Info
- Publication number
- ES2109512T3 ES2109512T3 ES93919327T ES93919327T ES2109512T3 ES 2109512 T3 ES2109512 T3 ES 2109512T3 ES 93919327 T ES93919327 T ES 93919327T ES 93919327 T ES93919327 T ES 93919327T ES 2109512 T3 ES2109512 T3 ES 2109512T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- cyclamenol
- sec
- macrolactam
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ZGISRQDECHVCPS-PYCSUBNKSA-N cyclamenol Chemical compound CC/1CNC(=O)\C=C\C=C/C=C\CC(O)\C=C\C=C/C=C\C=C\1 ZGISRQDECHVCPS-PYCSUBNKSA-N 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 241000203809 Actinomycetales Species 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION SE REFIERE AL CICLAMENOL DE SUSTANCIA NATURAL CON LA FORMULA (IA), UN PROCESO PARA SU ELABORACION A PARTIR DE MICROORGANISMOS DEL ORDEN DE LOS AMINOCETALES, EN PARTICULAR A PARTIR DEL TRONCO ESTREPTOMICES MHW 846, SUS DERIVADOS QUIMICOS ASI COMO SU UTILIZACION COMO MEDICAMENTO, EN PARTICULAR PARA ENFERMEDADES INFLAMATORIAS AGUADOS O CRONICAS EN EL CAMPO DE LA MEDICINA Y EN VETERINARIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4231289A DE4231289A1 (de) | 1992-09-18 | 1992-09-18 | Neuer Naturstoff Cyclamenol und chemische Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2109512T3 true ES2109512T3 (es) | 1998-01-16 |
Family
ID=6468283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93919327T Expired - Lifetime ES2109512T3 (es) | 1992-09-18 | 1993-09-13 | Macrolactama (ciclamenol) antiinflamatoria. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5565561A (es) |
EP (1) | EP0660825B1 (es) |
JP (1) | JPH08501687A (es) |
AT (1) | ATE160772T1 (es) |
CA (1) | CA2144747A1 (es) |
DE (2) | DE4231289A1 (es) |
DK (1) | DK0660825T3 (es) |
ES (1) | ES2109512T3 (es) |
GR (1) | GR3025682T3 (es) |
WO (1) | WO1994006774A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003296908A1 (en) * | 2002-09-27 | 2004-05-04 | Nereus Pharmaceuticals, Inc. | Macrocyclic lactams |
WO2009026527A1 (en) * | 2007-08-22 | 2009-02-26 | Novobiotic Pharmaceuticals Llc | Novel macrolactam compounds |
CN116199702A (zh) * | 2021-12-01 | 2023-06-02 | 上海交通大学医学院附属仁济医院 | 一种大环内酰胺类化合物、其制备方法及应用 |
-
1992
- 1992-09-18 DE DE4231289A patent/DE4231289A1/de not_active Withdrawn
-
1993
- 1993-09-13 CA CA002144747A patent/CA2144747A1/en not_active Abandoned
- 1993-09-13 AT AT93919327T patent/ATE160772T1/de not_active IP Right Cessation
- 1993-09-13 ES ES93919327T patent/ES2109512T3/es not_active Expired - Lifetime
- 1993-09-13 DK DK93919327T patent/DK0660825T3/da active
- 1993-09-13 WO PCT/EP1993/002472 patent/WO1994006774A1/de active IP Right Grant
- 1993-09-13 EP EP93919327A patent/EP0660825B1/de not_active Expired - Lifetime
- 1993-09-13 JP JP6507782A patent/JPH08501687A/ja active Pending
- 1993-09-13 DE DE59307796T patent/DE59307796D1/de not_active Expired - Fee Related
- 1993-09-13 US US08/397,208 patent/US5565561A/en not_active Expired - Fee Related
-
1997
- 1997-12-16 GR GR970403331T patent/GR3025682T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5565561A (en) | 1996-10-15 |
DK0660825T3 (da) | 1998-08-10 |
DE4231289A1 (de) | 1994-03-24 |
EP0660825B1 (de) | 1997-12-03 |
CA2144747A1 (en) | 1994-03-31 |
ATE160772T1 (de) | 1997-12-15 |
WO1994006774A1 (de) | 1994-03-31 |
JPH08501687A (ja) | 1996-02-27 |
DE59307796D1 (de) | 1998-01-15 |
EP0660825A1 (de) | 1995-07-05 |
GR3025682T3 (en) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO304889B1 (no) | Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer | |
FR2700117B1 (fr) | Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. | |
ZA952614B (en) | The use of carboxylic acid derivatives as drugs | |
NO981204L (no) | Selektive <beta>3 -adrenergiske agonister | |
FI964482A (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
DK0748314T3 (da) | Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
DK0609336T3 (da) | Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
ES2006619A6 (es) | Un metodo para preparar derivados de piridil-y pirimidil-piperazinas. | |
ES2109512T3 (es) | Macrolactama (ciclamenol) antiinflamatoria. | |
ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
DK0678089T3 (da) | N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser | |
DK0675895T3 (da) | Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling | |
NO950177L (no) | Farmakologisk aktive erivater | |
ATE190845T1 (de) | Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen | |
ATE170527T1 (de) | Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel | |
ES2161243T3 (es) | Imidazolo-quinoxalinonas para el tratamiento de enfermedades del sistema nervioso central. | |
AU673225B2 (en) | Triazoloquinazolines for the treatment of diseases of the central vervous system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 660825 Country of ref document: ES |